Novartis Investigator Site

Portland, Oregon 97227-1110

0 studies enrolling now · 5 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma — Completed
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of Different Doses of Indacaterol — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) — Completed